ArticleCancers2022

High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.

Anngela C Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.